Not applicableUnknownNCT01198808What this trial is testingTumorspecific T-cell Immunity in Bladder Cancer as Prognostic MarkerWho this might be right forBladder Cancer Technical University of Munich 50
Early research (Phase 1)Active Not RecruitingNCT03500991What this trial is testingHER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsWho this might be right forCentral Nervous System Tumor, PediatricGliomaEpendymoma+6 more Seattle Children's Hospital 10
Early research (Phase 1)Study completedNCT00104390What this trial is testingAssessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick TestingWho this might be right forType I Hypersensitivity Allergy Therapeutics 14
Testing effectiveness (Phase 2)Study completedNCT00081809What this trial is testingA Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent LymphomaWho this might be right forLymphoma, FollicularLymphoma, Small Lymphocytic Agenus Inc. 35
Testing effectiveness (Phase 2)Study completedNCT00001564What this trial is testingA Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric SarcomasWho this might be right forEwing's SarcomaRhabdomyosarcoma National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00012207What this trial is testingBiological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00157209What this trial is testingPhase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)Who this might be right forLung NeoplasmsCarcinoma, Non-Small-Cell Lung Merck KGaA, Darmstadt, Germany 171
Early research (Phase 1)Ended earlyNCT01106235What this trial is testingTherapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic MelanomaWho this might be right forStage IV Melanoma Fred Hutchinson Cancer Center 12
Early research (Phase 1)Active Not RecruitingNCT03635632What this trial is testingC7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Who this might be right forRelapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more Baylor College of Medicine 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729What this trial is testingA Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more Fred Hutchinson Cancer Center 53
Very early researchLooking for participantsNCT06252402What this trial is testingCMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDSWho this might be right forHIV-1 City of Hope Medical Center 15
Testing effectiveness (Phase 2)Ended earlyNCT01308294What this trial is testingImmunotherapy of HLA-A2 Positive Stage II-IV Melanoma PatientsWho this might be right forMelanoma Centre Hospitalier Universitaire Vaudois 16
Testing effectiveness (Phase 2)Study completedNCT00002786What this trial is testingBiological Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Fred Hutchinson Cancer Center 20
Early research (Phase 1)Looking for participantsNCT06193759What this trial is testingImmunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)Who this might be right forMedulloblastoma, ChildhoodAtypical Teratoid/Rhabdoid Tumor of CNSEmbryonal Tumor With Multilayered Rosettes+3 more Children's National Research Institute 12
Testing effectiveness (Phase 2)Ended earlyNCT00001827What this trial is testingP53 Vaccine for Ovarian CancerWho this might be right forOvarian Neoplasm National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT01012531What this trial is testingEfficacy and Safety of Specific Immunotherapy With CLUSTOID Grass PollenWho this might be right forAllergic Rhinitis Roxall Medizin 121
Early research (Phase 1)WithdrawnNCT00017537What this trial is testingVaccine Therapy in Treating Patients With Metastatic or Recurrent CancerWho this might be right forBreast CancerGastric CancerLung Cancer+2 more University of Alabama at Birmingham
Large-scale testing (Phase 3)Study completedNCT00623701What this trial is testingEfficacy and Safety From a High-dosed Sublingual Grass Pollen PreparationWho this might be right forAllergyRhinitisConjunctivitis Allergopharma GmbH & Co. KG 126
Early research (Phase 1)Study completedNCT00004881What this trial is testingVaccine Therapy in Treating Patients With Advanced CancerWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific Jonsson Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT03423992What this trial is testingPersonalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant GliomasWho this might be right forGliomaMalignant Glioma of BrainRecurrence Tumor Xuanwu Hospital, Beijing 100